S. 1695 (110th): Biologics Price Competition and Innovation Act of 2007
Jun 26, 2007
110th Congress, 2007–2009
Died in a previous Congress
This bill was introduced on June 27, 2007, in a previous session of Congress, but was not enacted.
Edward “Ted” Kennedy
Senator from Massachusetts
Read Text »
Last Updated: Nov 19, 2008
Length: 88 pages
About the bill
- Full Title
A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
- What is a bill?
The “S.” in “S. 1695” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
4 cosponsors (2R, 2D) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/s1695
“S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007.” www.GovTrack.us. 2007. May 4, 2015 <https://www.govtrack.us/congress/bills/110/s1695>
|title=S. 1695 (110th)
|accessdate=May 4, 2015
|author=110th Congress (2007)
|date=June 26, 2007
|quote=Biologics Price Competition and Innovation Act of 2007